Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Folks if you do not have plans to buy more shares yur
View:
Post by Dude51 on Feb 11, 2021 7:04pm

Folks if you do not have plans to buy more shares yur

going to be pissssed. Alice here we come. We made the right move on this one folks mark my words; Dude51 says this is one hell of an investment, patients is key.

Okay Robert you have my permission as a shareholder, you have my permission to buy out this  small start up company. I really must insist that we get with these folks el pronto.
I do not see a down side and I know you like to buy companies, 3rd time a charm? Talk with Mr. Salzman, get working on this acquisition,  you want to see a stock go ballistic? Do it, you can do it....
Even if we do not buy this start up company the fact were developing along the same line is huge.

https://omny.fm/shows/charles-adler-tonight/a-canadian-company-s-promising-solution-to-the-cov

GLTA
Comment by Captainblk on Feb 11, 2021 7:36pm
Comment by AngelaL on Feb 11, 2021 8:38pm
SaNOtize is making a noble effort to leverage the ability of nitric oxide to kill COVID-19 but the company's product cannot compete against Kalytera'a R-107. Why? Two reasons: 1) SaNOrize uses acidified nitrite to generate nitric oxide from the nasal spray while in the nose. The stuff has to be really acidic to turn nitrite into nitric oxide. Have you ever tried putting acid up your nose ...more  
Comment by Captainblk on Feb 11, 2021 9:28pm
quote=AngelaLSaNOtize is making a noble effort to leverage the ability of nitric oxide to kill COVID-19 but the company's product cannot compete against Kalytera'a R-107. Why? Two reasons: 1) SaNOrize uses acidified nitrite to generate nitric oxide from the nasal spray while in the nose. The stuff has to be really acidic to turn nitrite into nitric oxide. Have you ever tried putting acid ...more  
Comment by Scotty on Feb 11, 2021 9:36pm
Captainblk, as valuable as your research is, and I / the community does appreciate it, the bottom line is imo, KLY is just a shell company. It doesn't matter how good the science is (legit or not) this companies funcion is to generate funds for a privately owned asset. Period. We shareholders weill never see a return,. just constant dilution and infinite promises. KLY can change its name (and ...more  
Comment by Bvukmanic on Feb 11, 2021 9:58pm
(another)agreement with Salzman group: Claritas will enter into a strategic collaboration with the Salzman Group, under which the Salzman Group will make available to Claritas the full capabilities of Salzman Group, including their deep expertise in working with nitric oxide and nitric oxide releasing compounds (another)Private Placement with Echelon to fund a yet started Phase 1 Study:  ...more  
Comment by AngelaL on Feb 12, 2021 4:59am
You've misunderstood their point about differentiation betwrrm R-107 and inhaled NO. Kalytera is saying that R-107 is superior to the gaseous form of NO which is hard to administer (bulky equipment, need for respiratory therapist) and expensive. Which is where R-107 comes in: cheaper and simpler to give, long half life, inexpensive. 
Comment by Dude51 on Feb 12, 2021 7:34am
I never missunderstood anything. All I am saying is good news for SaNOtize is good news for us. Listen to my previous post. Any news on NO is good news. I kinda dought your conclusion "Bottom line: SaNOtize has little chance of medical or commercial success." If SaNOtize kills covid in the nose and throat before it can infect the rest of the body it will be successful imo. SaNOtize ...more  
Comment by Scotty on Feb 12, 2021 9:46am
"dought"
Comment by Scotty on Feb 11, 2021 9:26pm
Do you have a plan B Dude51?
Comment by Dude51 on Feb 11, 2021 10:48pm
Buy more, you?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities